Nordic Trial Alliance aims to increase the number of clinical trials in the Nordic region. A call has been issued with 6 million Norwegian kroner aimed to support ongoing Nordic clinical research studies or expansion of ongoing national studies into Nordic ones.
Det nordiske initiativet for helse og velferd har som målsetting å bedre helsen i de nordiske landene ved å finne løsninger på samfunns- og folkehelseutfordringer gjennom fremragende forskning.
Cancer in children is rare. But cancer remains the disease causing the most deaths in children over the age of 1 year. Most children, who die from cancer, do so because the standard treatment doesn't make their disease disappear (resistant disease) or because the disease returns (relapse of the disease). These children are at a high risk of dying from their cancer and we need to develop new treatments for them.
The Nordic Society of Paediatric Haematology and Oncology (NOPHO), established in 1984, has been a successful and productive society leading to improved survival rates of childhood leukemias, Acute Lymphoblastic Leukemia (ALL) and Acute Myeloblastic Leukemia (AML).
Scientific content: The main focus of the current course will be to give an overview of Nordic health research based on register data and introduce a wide range of epidemiologic methods relevant for this type of data. Important health registers, and other Nordic registers relevant for register research will be presented.
The graduate course «Register-based research: Pharmacoepidemiology - drug use and safety» will provide junior researchers with knowledge on how to conduct register-based research across the Nordic countries.
Children in the Nordic Countries are offered many vaccines that protect against a wide variety of specific infectious diseases. Studies from low-income countries indicate that vaccines might also alter the resistance towards other diseases.
